CDC Awards $148 Million Contract for Emergency Diagnostic Test Development
The five-year agreement with MRIGlobal aims to enhance laboratory readiness and response for public health emergencies.
Read More
Search Results for: covid-19
New Program Aims to Fill Long COVID Diagnostic Gap With Validated Tests
PolyBio Research Foundation has launched a $1.35 million program at UCSF to compare and validate diagnostic tests for long COVID, aiming to address the lack of standardized clinical diagnostics in the field.
Read More
Co-Diagnostics Joint Venture to Build Molecular Diagnostics Facility in Saudi Arabia
Co-Diagnostics and Arabian Eagle Manufacturing have secured land in Sudair Industrial City, Saudi Arabia, to build a facility for manufacturing molecular diagnostic instruments and assays, supporting regional expansion in the Middle East and North Africa.
Read More
Rapid Molecular Test for Flu and COVID-19 on FINDER Platform Gets FDA Clearance and CLIA-Waiver
The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.
Read More
FDA Grants CLIA Waiver for Rapid Test That Differentiates Bacterial and Non-Bacterial Respiratory Infections
The FDA has granted a CLIA waiver for FebriDx, enabling its use in over 300,000 U.S. point-of-care settings and potentially reaching 80 million patients annually, according to PHASE Scientific.
Read More